Cataldi Fabio 4
4 · Landos Biopharma, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Cataldi Fabio
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-28+184,500→ 184,500 totalExercise: $0.37Exp: 2033-02-27→ Common Stock (184,500 underlying) - Award
Restricted Stock Unit
2023-02-28+276,750→ 276,750 totalExp: 2033-02-27→ Common Stock (276,750 underlying)
Footnotes (3)
- [F1]1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
- [F2]Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
- [F3]The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.